drugset / Trial / NCT00379600
The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess whether the anti-inflammatory effects of rosiglitazone result in improvements in Rheumatoid Arthritis symptoms in patients for whom their existing Disease Modifying Anti-Rheumatic Drug (DMARD) treatment does not give adequate relief.
Timeline
- Start
- 2004-11
- Primary completion
- 2006-12
- Completion
- 2006-12
Publications
- Background This study has not been published in the scientific literature.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | 8 mg | — |